HUDSON— If Columbia Memorial Health does not change its designation, it might be forced to close. That was the message from CMH CEO Dorothy Urschel and other hospital and Albany Med Health System ...

”The Typewriter and the Guillotine: An American Journalist, a German Serial Killer and Paris on the Eve of WWII,” By Mark Braude. Publisher: Grand Central, 415 pages. $27. One half of “The Typewriter ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The Trump administration is moving forward with a personnel rule that ...

STOUGHTON, Wis. -- Stoughton police said they used a drone to catch a "serial defecator" in the act at a city park Thursday morning. Police began investigating after multiple residents reported ...

Gov. Mike Kehoe announced that Missouri counties, towns and cities can now apply to be recognized as Blue Shield communities in 2026 for their dedication to effective law enforcement and community ...

UC Berkeley announced Jan. 29 that it was named a Black-Serving Institution, or BSI, in December 2025. The recognition came as part of an inaugural group of California colleges and universities ...

Town leaders in Lenox — working with Lee and Williamstown — and Stockbridge, on its own, are planning to explore the pros and cons of participating in the state’s voluntary Seasonal Communities ...

Manning Family Children's Hospital in New Orleans is the first hospital in Louisiana and the Gulf South to become a Level 1 pediatric trauma center, a designation that means the hospital can treat ...

Eli Lilly has won U.S. Food and Drug Administration breakthrough -therapy designation for its sofetabart mipitecan drug candidate for certain patients with ovarian cancer. Eli Lilly on Tuesday said ...

COLUMBUS, Ohio — A serial prowler was arrested Thursday in connection with multiple burglary and rape attempts in northwest Columbus, according to police and court records. According to a Facebook ...

SEATTLE, Jan. 16, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other ...